Goodbody Health Inc banner
G

Goodbody Health Inc
OTC:GDBYF

Watchlist Manager
Goodbody Health Inc
OTC:GDBYF
Watchlist
Price: 0 USD Market Closed
Market Cap: $0

Goodbody Health Inc
Investor Relations

Goodbody Health, Inc. operates as a health and wellness company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2015-09-21. The firm operates both in wellness testing in the United Kingdom and as a vertically integrated cannabinoid (CBD) company that operates in the United Kingdom and the European Union. The company operates under one segment: the sale of cannabinoid products and clinic and cannabinoid testing. The firm focuses on offering COVID and blood testing clinics, CBD extraction, wholesale bulk isolate and distillate sales, retail CBD and white label sales, cannabinoid laboratory testing, and medicinal cannabis research programs. The company provides a local level network of approximately 140 clinics, providing over 30 blood and polymerase chain reaction (PCR) tests for at home or in clinic testing. The Company’s subsidiaries include Borganic, Olimax, Olimax RE, Sativa Wellness Group Poland, Sativa Group, Goodbody Botanicals and Phytovista Laboratories.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Geremy Howard Prance Thomas
Founder & Non-Executive Chairman of the Board
No Bio Available
Mr. George Thomas
Chief Executive Officer & Director
No Bio Available
Ms. Anne Tew A.C.I.S., FCCA
Company Secretary
No Bio Available
Mr. Jason Dussault
Corporate Communications Director & Head of IR
No Bio Available
Dr. John Pettit
Chief Medical Advisor
No Bio Available

Contacts

Address
BRITISH COLUMBIA
Vancouver
503-905 West Pender St.
Contacts
+16043657097.0
goodbodyhealth.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett